Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance.

International Journal of Molecular Sciences
Sol-Bi ShinHyungshin Yim

Abstract

USP7 is a promising target for the development of cancer treatments because of its high expression and the critical functions of its substrates in carcinogenesis of several different carcinomas. Here, we demonstrated the effectiveness of targeting USP7 in advanced malignant cells showing high levels of USP7, especially in taxane-resistant cancer. USP7 knockdown effectively induced cell death in several cancer cells of lung, prostate, and cervix. Depletion of USP7 induced multiple spindle pole formation in mitosis, and, consequently, resulted in mitotic catastrophe. When USP7 was blocked in the paclitaxel-resistant lung cancer NCI-H460TXR cells, which has resistance to mitotic catastrophe, NCI-H460TXR cells underwent apoptosis effectively. Furthermore, combination treatment with the mitotic kinase PLK1 inhibitor volasertib and the USP7 inhibitor P22077 showed a strong synergism through down-regulation of MDR1/ABCB1 in paclitaxel-resistant lung cancer. Therefore, we suggest USP7 is a promising target for cancer therapy, and combination therapy with inhibitors of PLK1 and USP7 may be valuable for treating paclitaxel-resistant cancers, because of their strong synergism.

References

Mar 3, 1993·Journal of the National Cancer Institute·W K MurphyM N Raber
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Mar 28, 2002·Physiological Reviews·Michael H Glickman, Aaron Ciechanover
Oct 25, 2003·Oncogene·George A OrrSusan Band Horwitz
Apr 1, 2004·Molecular Cell·Muyang LiWei Gu
Apr 2, 2004·Nature Reviews. Cancer·Mary Ann Jordan, Leslie Wilson
Apr 3, 2004·Nature·Jordan M CumminsBert Vogelstein
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Jan 26, 2007·Nature Reviews. Cancer·Jeffrey R JacksonPearl S Huang
Aug 13, 2009·Molecular Cancer Therapeutics·Frédéric CollandLaurent Daviet
Sep 17, 2009·Biochemical Society Transactions·David Komander
Dec 21, 2010·Nature Cell Biology·Mirjam T EppingRené Bernards
Apr 24, 2012·Chemistry & Biology·Céline ReverdyFrédéric Colland
Mar 19, 2014·Mutation Research. Reviews in Mutation Research·Hyungshin Yim, Raymond L Erikson
Jul 9, 2014·Oncotarget·Serena GiovinazziAlexander M Ishov
Dec 19, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Guang-Yin ZhaoJian-Yong Ding
Nov 11, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Viktoria VolkUlrich Mey
Mar 5, 2016·The New England Journal of Medicine·John K ChanBradley J Monk
May 18, 2016·The Journal of Clinical Investigation·Qian WangLei Shi
Jun 16, 2016·The Tohoku Journal of Experimental Medicine·Li ZhangHaixia Li
Jun 19, 2016·Cancer Chemotherapy and Pharmacology·Seiji YoshitomiToshiharu Mitsuhashi
Sep 4, 2016·The International Journal of Biochemistry & Cell Biology·Chao ZhangFeng-Hou Gao
Feb 22, 2017·Biochemical Pharmacology·Tao AnYan Li
Oct 20, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Mengying WangHan Liu
Feb 28, 2018·Epigenetics & Chromatin·Olya YarychkivskaTimothy H Bestor
Jun 4, 2019·Therapeutic Advances in Medical Oncology·Sol-Bi ShinHyungshin Yim
Sep 14, 2019·Future Medicinal Chemistry·Sven Marcel Stefan
Nov 16, 2019·Journal of Experimental & Clinical Cancer Research : CR·Yuchong PengXiong Li

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
deubiquitination
Reverse Transcription Polymerase Chain Reaction

Software Mentioned

Delta vision

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis